Company number 09981769
Status Active
Incorporation Date 2 February 2016
Company Type Private Limited Company
Address 10 ASTON PARK, ASTON ROWANT, WATLINGTON, OXFORDSHIRE, UNITED KINGDOM, OX49 5SW
Home Country United Kingdom
Nature of Business 72110 - Research and experimental development on biotechnology
Phone, email, etc
Since the company registration ten events have happened. The last three records are Statement of capital following an allotment of shares on 8 February 2017
GBP 170.588
; Confirmation statement made on 1 February 2017 with updates; Resolutions
RES10 ‐
Resolution of allotment of securities
RES11 ‐
Resolution of removal of pre-emption rights
RES01 ‐
Resolution of adoption of Articles of Association
. The most likely internet sites of FAST BIOPHARMA LTD are www.fastbiopharma.co.uk, and www.fast-biopharma.co.uk. The predicted number of employees is 1 to 10. The company’s age is nine years and ten months. The distance to to Saunderton Rail Station is 5.3 miles; to Haddenham & Thame Parkway Rail Station is 6 miles; to Monks Risborough Rail Station is 6.2 miles; to Aylesbury Rail Station is 10.6 miles is 2.7 miles. This is straight distance. Please bear in mind the walking distance could be longer.Fast Biopharma Ltd is a Private Limited Company.
The company registration number is 09981769. Fast Biopharma Ltd has been working since 02 February 2016.
The present status of the company is Active. The registered address of Fast Biopharma Ltd is 10 Aston Park Aston Rowant Watlington Oxfordshire United Kingdom Ox49 5sw. . BROWN, Claire, Dr is a Director of the company. CHAPLIN, David John, Dr is a Director of the company. DAVIS, Peter David, Dr is a Director of the company. The company operates in "Research and experimental development on biotechnology".
Current Directors
Persons With Significant Control
Dr Peter David Davis
Notified on: 6 April 2016
69 years old
Nature of control: Ownership of shares – More than 25% but not more than 50%
FAST BIOPHARMA LTD Events
08 Feb 2017
Statement of capital following an allotment of shares on 8 February 2017
08 Feb 2017
Confirmation statement made on 1 February 2017 with updates
23 Jun 2016
Resolutions
-
RES10 ‐
Resolution of allotment of securities
-
RES11 ‐
Resolution of removal of pre-emption rights
-
RES01 ‐
Resolution of adoption of Articles of Association
21 Jun 2016
Statement of capital following an allotment of shares on 14 June 2016
15 Jun 2016
Appointment of Dr Claire Brown as a director on 14 June 2016
...
... and 0 more events
14 Jun 2016
Appointment of Dr David John Chaplin as a director on 14 June 2016
22 Apr 2016
Sub-division of shares on 8 April 2016
22 Apr 2016
Statement of capital following an allotment of shares on 8 April 2016
22 Apr 2016
Resolutions
-
RES11 ‐
Resolution of removal of pre-emption rights
-
RES13 ‐
Shares sub-divided 08/04/2016
-
RES10 ‐
Resolution of allotment of securities
02 Feb 2016
Incorporation
Statement of capital on 2016-02-02
-
MODEL ARTICLES ‐
Model articles adopted